Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Co-beneldopa (Benserazide/levodopa)
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Co-beneldopa 25mg/100mg capsules
0409010K0AAAJAJ
|
Co-beneldopa | Co-beneldopa (Benserazide/levodopa) | Central Nervous System | 48,940 |
|
Co-beneldopa 12.5mg/50mg capsules
0409010K0AAAIAI
|
Co-beneldopa | Co-beneldopa (Benserazide/levodopa) | Central Nervous System | 46,533 |
|
Madopar 100mg/25mg capsules
0409010K0BBAKAJ
|
Madopar | Co-beneldopa (Benserazide/levodopa) | Central Nervous System | 36,023 |
|
Madopar 50mg/12.5mg capsules
0409010K0BBAIAI
|
Madopar | Co-beneldopa (Benserazide/levodopa) | Central Nervous System | 29,894 |
|
Co-beneldopa 25mg/100mg modified-release capsules
0409010K0AAAFAF
|
Co-beneldopa | Co-beneldopa (Benserazide/levodopa) | Central Nervous System | 27,179 |
|
Co-beneldopa 12.5mg/50mg dispersible tablets sugar free
0409010K0AAAMAM
|
Co-beneldopa | Co-beneldopa (Benserazide/levodopa) | Central Nervous System | 20,846 |
|
Madopar CR capsules
0409010K0BBANAF
|
Madopar | Co-beneldopa (Benserazide/levodopa) | Central Nervous System | 20,252 |
|
Madopar 50mg/12.5mg dispersible tablets
0409010K0BBAJAM
|
Madopar | Co-beneldopa (Benserazide/levodopa) | Central Nervous System | 18,942 |
|
Co-beneldopa 25mg/100mg dispersible tablets sugar free
0409010K0AAALAL
|
Co-beneldopa | Co-beneldopa (Benserazide/levodopa) | Central Nervous System | 9,749 |
|
Madopar 100mg/25mg dispersible tablets
0409010K0BBALAL
|
Madopar | Co-beneldopa (Benserazide/levodopa) | Central Nervous System | 6,957 |
|
Co-beneldopa 50mg/200mg capsules
0409010K0AAAKAK
|
Co-beneldopa | Co-beneldopa (Benserazide/levodopa) | Central Nervous System | 4,985 |
|
Madopar 200mg/50mg capsules
0409010K0BBAMAK
|
Madopar | Co-beneldopa (Benserazide/levodopa) | Central Nervous System | 4,324 |
|
Co-beneldopa 12.5mg/50mg/5ml oral suspension
0409010K0AAANAN
|
Co-beneldopa | Co-beneldopa (Benserazide/levodopa) | Central Nervous System | No data available |
|
Co-beneldopa 25mg/100mg/5ml oral liquid
0409010K0AAAHAH
|
Co-beneldopa | Co-beneldopa (Benserazide/levodopa) | Central Nervous System | No data available |
|
Co-beneldopa 25mg/6.25mg/5ml oral suspension
0409010K0AAAPAP
|
Co-beneldopa | Co-beneldopa (Benserazide/levodopa) | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.